Hypersensitivity to inhaled TOBI following reaction to gentamicin

Pediatric Pulmonology
Michael G SpigarelliSamya Z Nasr

Abstract

Cystic fibrosis (CF) is the most common autosomal-recessive disease in Caucasians. Colonization with Pseudomonas aeruginosa (P. aeruginosa) of the CF airways causes deterioration of pulmonary status. TOBI (Tobramycin solution for inhalation) is an inhaled antibiotic that can improve the pulmonary disease. We report on a 9-year old boy with CF who developed a rash following a course of IV gentamicin. The rash resolved after its discontinuation. However, the rash returned all over his body, with the start of inhalation of TOBI therapy. We desensitized the patient using escalating doses of inhaled TOBI. He tolerated the procedure well, and continues to be on TOBI 9 months after desensitization on a once-a-day regimen.

References

May 1, 1990·Contact Dermatitis·F Menéndez RamosM V Merino Luque
Mar 1, 1987·The Journal of Allergy and Clinical Immunology·H S Earl, T J Sullivan
Apr 1, 1973·Archives of Dermatology·W F SchorrS I Hededus
Jun 1, 1994·The Journal of Allergy and Clinical Immunology·N AbsarG Beall
Jul 1, 1995·The Annals of Pharmacotherapy·J S Schretlen-Doherty, W G Troutman
Mar 1, 1996·Contact Dermatitis·D MunozL F Fernandez De Corres

❮ Previous
Next ❯

Citations

Feb 13, 2003·Allergy·S Schulze, U Wollina
Jun 25, 2008·Surgical Laparoscopy, Endoscopy & Percutaneous Techniques·B Haluk GüvençBurak Erkus
Jun 1, 2005·Thorax·J S Parmar, S Nasser
Sep 3, 2011·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A LiuM Castells
Nov 2, 2013·The World Allergy Organization Journal·Mario Sánchez-BorgesMaria José Torres Jaén
Sep 1, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Lindsey M Childs-KeanJonathan C Cho
Aug 31, 2019·Pediatric Clinics of North America·Shazia Lutfeali, David A Khan
Feb 24, 2021·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Sophia Tsabouri, Marina Atanaskovic-Markovic
Oct 12, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Ana Dioun BroylesMariana Castells
Apr 20, 2021·Frontiers in Pediatrics·Justyna SieberZsolt Szépfalusi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.